Related Experiment Video
Updated: Aug 9, 2026

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
Published on: November 1, 2014
Endothelin receptor alterations in equine airway hyperreactivity
Changaram S Venugopal1, Sumanth Polikepahad, Earnestine P Holmes
1Equine Health Studies Program, Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana 70803, USA. cvenugopal@vetmed.lsu.edu
Endothelin-1 (ET-1) causes airway hyperreactivity in horses with summer pasture-associated obstructive pulmonary disease (SPAOPD). This response is linked to ET(B) receptor activation in affected horses, unlike in healthy horses.
Area of Science:
- Veterinary Medicine
- Pulmonary Physiology
- Pharmacology
Background:
- Summer pasture-associated obstructive pulmonary disease (SPAOPD) is a common respiratory condition in horses.
- Endothelin-1 (ET-1) is a potent vasoconstrictor and mediator of airway tone.
- The role of ET-1 and its receptors in equine SPAOPD remains incompletely understood.
Purpose of the Study:
- To investigate the involvement of endothelin-1 (ET-1) and its receptors in the airway hyperreactivity observed in horses with SPAOPD.
- To compare the effects of ET-1 and its receptor antagonists on bronchial smooth muscle from healthy and SPAOPD-affected horses.
Main Methods:
- Bronchial rings from healthy and SPAOPD-affected horses were used in organ bath studies.
- The effects of ET-1 and specific ET(A) and ET(B) receptor antagonists (BQ-123 and IRL-1038) on bronchial contraction were assessed.
- Reverse-transcription polymerase chain reaction (RT-PCR) was employed to evaluate ET(B)-receptor gene expression.
Main Results:
- Horses with SPAOPD exhibited significantly greater ET-1-induced bronchial contraction compared to healthy horses.
- ET(A)-receptor blockade enhanced ET-1 responses in healthy horses, while ET(B)-receptor blockade reduced responses in SPAOPD-affected horses.
- SPAOPD-affected horses showed increased ET(B)-receptor affinity and a trend towards increased ET(B)-receptor mRNA expression.
Conclusions:
- Airway hyperreactivity to ET-1 in horses with SPAOPD is partly mediated by the activation of pulmonary ET(B) receptors.
- ET(B) receptors appear to play a more significant role in the airway smooth muscle of SPAOPD-affected horses than in healthy horses.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

